Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2025.
-
Busy address KBO
20 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Clinigen Clinical Supplies Management from Mont-Saint-Guibert, company number BE0859906087, closed financial year 2025 with a result of € 878,779 after tax. For that financial year Clinigen Clinical Supplies Management recorded revenue of € 56.8 million and equity of € 18.9 million. Compared with financial year 2023, the result moved from € 3.3 million to € 878,779. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on February 10, 2026.
€ 18.9 million
▲ 24% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 878,779
▼ 74% vs 2023
Profit after tax over the fiscal year.
€ 3.7 million
▲ 223% vs 2023
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 18.4 million.
People and assets in 2025
119
▼ 22.6 vs 2023
Average over the fiscal year, from the social balance sheet.
€ 11.3 million
▼ 2% vs 2023
€ 94,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 278,849
▼ 84% vs 2023
Of which on lease € 148,823.
Debts at end 2025
€ 2.2 million
▼ 31% vs 2023
€ 433,407 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.
€ 2.8 million
▼ 43% vs 2023
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 23 days on average.
€ 3 million
▲ 35% vs 2023
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2025 | Change 2023 → 2025 | |
|---|---|---|---|---|
| Revenue | € 74,605,907 | € 43,436,661 | € 56,816,786 | ▲ 31% |
| Profit after taxes | € 3,086,555 | € 3,328,274 | € 878,779 | ▼ 74% |
| Equity | € 11,878,514 | € 15,206,788 | € 18,925,337 | ▲ 24% |
| Total debts | € 19,566,465 | € 10,389,702 | € 25,974,439 | ▲ 150% |
| Cash | € 7,108,992 | € 1,157,506 | € 3,739,414 | ▲ 223% |
| Retained profit | € 11,369,674 | € 14,697,948 | € 18,416,497 | ▲ 25% |
| Bank debt | € 3,870,012 | € 3,232,456 | € 2,245,086 | ▼ 31% |
| Balance sheet total | € 31,444,979 | € 25,638,159 | € 44,899,776 | ▲ 75% |
| Employees (FTE) | 140.1 | 141.6 | 119 | ▼ 22.6 |
Key figures of Clinigen Clinical Supplies Management, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to Clinigen Clinical Supplies Management?
What happened at Clinigen Clinical Supplies Management in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Veronique Beautrix stepped down as director. NBB
- Richard Paling stepped down as director. NBB
- Corrected annual accounts filed for financial year 2025. filed late Source: NBB ↗
- Isabelle Bertaggia stepped down as director. NBB
- Gunter Van Hoof stepped down as director. NBB
- Veronique Beautrix became a director. NBB
- Gunter Van Hoof became a director. NBB
- Isabelle Bertaggia became a director. NBB
In short
From € 3.1 million profit in 2022 to € 878,779 profit in 2025.
Paid € 3 million in corporate taxes since 2022.
Best year ever: 2023, with € 3.3 million profit.
Pays suppliers within 23 days on average.
A new publication or filing at Clinigen Clinical Supplies Management? We notify you, reason included.
Follow Clinigen Clinical Supplies ManagementDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The shares are held by CLINIGEN CLINICAL SUPPLIES MANAGEMENT BELGIUM (99.6%) and Clinigen Clinical Supplies Management (0.5%).
Directors
According to the 2025 annual accounts
since 2023 · until 2025
Veronique Beautrix
Director
since 2024 · until 2030
since 2020 · until 2026
since 2023 · until 2026
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue Granbonpré 11
1435 Mont-Saint-Guibert
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 20 companies are registered at this address.
All companies at this address →DE SMET AGRO
€ 8.7 million revenue · 2025
DE SMET S.A. - ENGINEERS & CONTRACTORS
€ 31.8 million revenue · 2025
CEDRIC CLAERHOUDT
€ 937,969 gross margin · 2024
Tools4Patient
€ -431,027 gross margin · 2025
NOVADIP BIOSCIENCES
€ 1.6 million gross margin · 2025
+15 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0859.906.087
- VAT number
- BE 0859.906.087
- Registered office
- Rue Granbonpré 11, 1435 Mont-Saint-Guibert
- Names & denominations
- Clinigen Clinical Supplies Management
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 1 August 2003
- Peppol
- Active · Active since 8 Dec 2025
- Contact
- [email protected] 010/237.444
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Goederenvervoer over de weg
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Verpakkingsbedrijven
Overige opslag
Overige ondersteunende activiteiten i.v.m. het vervoer te land
Activiteiten van verpakkingsbedrijven
+2